Michael-Jubeli R et al. |
High-temperature gas chromatography-mass spectrometry for skin surface lipids profiling. |
2011 |
J. Lipid Res. |
pmid:20952798
|
Lama-Muñoz A et al. |
New hydrothermal treatment of alperujo enhances the content of bioactive minor components in crude pomace olive oil. |
2011 |
J. Agric. Food Chem. |
pmid:21265536
|
Ellebedy AH et al. |
Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21270336
|
Morel S et al. |
Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity. |
2011 |
Vaccine |
pmid:21256188
|
Sarpietro MG et al. |
Synthesis of n-squalenoyl cytarabine and evaluation of its affinity with phospholipid bilayers and monolayers. |
2011 |
Int J Pharm |
pmid:21219999
|
Brasser AJ et al. |
Presence of wax esters and squalene in human saliva. |
2011 |
Arch. Oral Biol. |
pmid:21247555
|
Arguedas A et al. |
Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age. |
2011 |
Hum Vaccin |
pmid:21285531
|
Manuel O et al. |
Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients. |
2011 |
Clin. Infect. Dis. |
pmid:21288852
|
Alghisi F et al. |
Immunogenicity and safety profile of the monovalent A/H1N1 MF59-adjuvanted vaccine in patients affected by cystic fibrosis. |
2011 |
Thorax |
pmid:21228426
|
Decaro N et al. |
Immunogenicity and protective efficacy in dogs of an MF59â„¢-adjuvanted vaccine against recombinant canine/porcine coronavirus. |
2011 |
Vaccine |
pmid:21272607
|
Arias JL et al. |
Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics. |
2011 |
ACS Nano |
pmid:21275408
|
Fenoglio D et al. |
MF-59 adjuvant influence on the functions of gammadelta T cells in HIV-1+ adults immunized with influenza seasonal vaccine. |
2011 |
J Prev Med Hyg |
pmid:22010544
|
Precioso AR et al. |
A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems. |
2011 |
Vaccine |
pmid:21945258
|
Pariani E et al. |
Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy. |
2011 |
Vaccine |
pmid:21974995
|
Andrews NJ et al. |
Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines. |
2011 |
Vaccine |
pmid:21875635
|
Vesikari T et al. |
Oil-in-water emulsion adjuvant with influenza vaccine in young children. |
2011 |
N. Engl. J. Med. |
pmid:21995388
|
Bernstein DI |
Vaccines for cytomegalovirus. |
2011 |
Infect Disord Drug Targets |
pmid:22309618
|
Fox CB et al. |
Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions. |
2011 |
Pharm Dev Technol |
pmid:20550484
|
Niehaus TD et al. |
Identification of unique mechanisms for triterpene biosynthesis in Botryococcus braunii. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21746901
|
Cheong HJ et al. |
Immunogenicity and safety of the influenza A/H1N1 2009 inactivated split-virus vaccine in young and older adults: MF59-adjuvanted vaccine versus nonadjuvanted vaccine. |
2011 |
Clin. Vaccine Immunol. |
pmid:21715575
|
Huijskens E et al. |
Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population. |
2011 |
Clin. Vaccine Immunol. |
pmid:21795459
|
Pollard AJ and Hill AV |
Antibody repertoire: embracing diversity. |
2011 |
Sci Transl Med |
pmid:21795586
|
Okike IO et al. |
The immunogenicity of a novel A (H1N1) vaccine in HIV-infected children. |
2011 |
Vaccine |
pmid:21742005
|
Kowert BA and Watson MB |
Diffusion of organic solutes in squalane. |
2011 |
J Phys Chem B |
pmid:21780767
|
Mackay D and Jones PJ |
Evaluation of methods for the determination of cholesterol absorption and synthesis in humans. |
2011 |
Atherosclerosis |
pmid:21763652
|
Jawaid AM et al. |
Shape-controlled colloidal synthesis of rock-salt lead selenide nanocrystals. |
2011 |
ACS Nano |
pmid:21770427
|
Oliaro-Bosso S et al. |
Characterization of the channel constriction allowing the access of the substrate to the active site of yeast oxidosqualene cyclase. |
2011 |
PLoS ONE |
pmid:21811565
|
Bildstein L et al. |
Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes. |
2011 |
Eur J Pharm Biopharm |
pmid:21784150
|
Della Cioppa G et al. |
Trivalent and quadrivalent MF59(®)-adjuvanted influenza vaccine in young children: a dose- and schedule-finding study. |
2011 |
Vaccine |
pmid:21906647
|
Fox CB et al. |
Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions. |
2011 |
Vaccine |
pmid:21906648
|
Zuccotti GV et al. |
Long-lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59-adjuvanted vaccine when co-administered with a 2009-2010 seasonal influenza vaccine in young patients with type 1 diabetes mellitus. |
2011 |
Diabet. Med. |
pmid:21916971
|
Meyer K et al. |
A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection. |
2011 |
PLoS ONE |
pmid:21887300
|
Broeders NE et al. |
Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study. |
2011 |
Clin J Am Soc Nephrol |
pmid:21921153
|
Achiraman S et al. |
Increased squalene concentrations in the clitoral gland during the estrous cycle in rats: an estrus-indicating scent mark? |
2011 |
Theriogenology |
pmid:21924481
|
Weyermann C et al. |
Initial results on the composition of fingerprints and its evolution as a function of time by GC/MS analysis. |
2011 |
J. Forensic Sci. |
pmid:20707835
|
Iannazzo S |
Pharmacoeconomic evaluation of the MF59--adjuvanted influenza vaccine in the elderly population in Italy. |
2011 |
J Prev Med Hyg |
pmid:21710816
|
Seubert A et al. |
Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21690334
|
Khurana S et al. |
MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines. |
2011 |
Sci Transl Med |
pmid:21632986
|
Zhang LW et al. |
Oil components modulate the skin delivery of 5-aminolevulinic acid and its ester prodrug from oil-in-water and water-in-oil nanoemulsions. |
2011 |
Int J Nanomedicine |
pmid:21556344
|
Lens M and Podesta Marty MH |
Assessment of the kinetics of the antioxidative capacity of topical antioxidants. |
2011 |
J Drugs Dermatol |
pmid:21369642
|
Cristiani C et al. |
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district. |
2011 |
Vaccine |
pmid:21396903
|
Tabache F et al. |
Acute polyarthritis after influenza A (H1N1) immunization. |
2011 |
Joint Bone Spine |
pmid:21444232
|
Sun Y et al. |
A reproducible in-vivo model of lymphatic malformation in rats. |
2011 |
J. Comp. Pathol. |
pmid:21419420
|
Meier S et al. |
Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children. |
2011 |
Vaccine |
pmid:21419775
|
Réjiba S et al. |
Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer. |
2011 |
Nanomedicine |
pmid:21419876
|
Banzhoff A et al. |
Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations. |
2011 |
Hum Vaccin |
pmid:21422814
|
Parretta E et al. |
Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination. |
2011 |
Vaccine |
pmid:21406267
|
Ambike A et al. |
Interaction of self-assembled squalenoyl gemcitabine nanoparticles with phospholipid-cholesterol monolayers mimicking a biomembrane. |
2011 |
Langmuir |
pmid:21413743
|
Gao J et al. |
Laser-induced acoustic desorption/atmospheric pressure chemical ionization mass spectrometry. |
2011 |
J. Am. Soc. Mass Spectrom. |
pmid:21472571
|
Esposito S et al. |
An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients. |
2011 |
Nephrol. Dial. Transplant. |
pmid:20974645
|